For this position, the recruiting organisation is the Istituto Superiore di Sanità (ISS) in Rome, Italy. The selected candidate will be employed by ISS and embedded in the international and interdisciplinary POLARIS consortium. Academic supervision will be provided by Dr Elena Ambrosini, with disease-specific expertise from Dr Angela Lanciotti and Dr Maria Stefania Brignone at the Department of Neuroscience of ISS, as well as academic support from Prof. Maria Egle De Stefano at Sapienza University of Rome.

Department of Neuroscience, Istituto Superiore di Sanità, Rome
The Department of Neuroscience at the Istituto Superiore di Sanità conducts research into both common and rare neurological disorders, including leukodystrophies. Its work focuses on understanding disease mechanisms, developing approaches for early diagnosis, and identifying new therapeutic targets and treatment strategies. An important part of the department’s mission is the translation of promising research findings into applications that can improve patient care and quality of life. Within POLARIS, ISS contributes expertise in leukodystrophies and iPSC-derived cell models.
This doctoral project focuses on the preclinical evaluation of pharmacological therapies for megalencephalic leukoencephalopathy with subcortical cysts (MLC), a rare leukodystrophy.
The candidate will use human in vitro models, including astrocytes and brain organoids generated from induced pluripotent stem cells (iPSCs) of individuals with MLC and healthy controls. These models will be used to investigate disease-relevant phenotypes through cellular, molecular, biochemical, imaging and omics approaches. They will also support compound screening and the evaluation of potential therapeutic strategies.
The project combines stem cell-based disease modelling, neuroscience and translational research. Planned secondments within the POLARIS consortium will provide additional interdisciplinary training, including exposure to complementary preclinical and computational approaches relevant to therapy development.
The academic embedding will be at ISS, with anticipated academic linkage to Sapienza University of Rome and full participation in the broader POLARIS doctoral training programme.
Important, strict eligibility criteria according to MARIE SKLODOWSKA CURIE programs apply to applicants:
- You must not already hold a doctoral degree.
- At the time of the application deadline, you must have a Master’s degree and must not have resided or carried out your main activity (work, studies, etc.) in the Netherlands for more than 12 months in the three years prior to the contract start date.
- You will participate in the network-wide training programme of POLARIS, which includes (international) training activities and planned secondments with POLARIS partner organizations throughout the EU.
We are looking for a motivated candidate with a Master’s degree in neuroscience, biomedical sciences, molecular biology, biotechnology or a related field. You have a strong interest in stem cell-based disease modelling, translational neuroscience and rare disease research.
Experience with cell culture, molecular and cellular biology techniques, microscopy, biochemical assays or omics-related approaches is considered an advantage. Familiarity with iPSC-derived models, astrocyte biology, organoid systems or pharmacological testing would be particularly valuable for this project.
You work accurately and reproducibly, have strong analytical skills and are able to collaborate effectively in an interdisciplinary and international research environment.
- A contract for 12 months, with the intention to extend for a total of 3 years;
- Salary, mobility allowance and benefits according to the applicable MSCA Doctoral Network and host-organisation rules;
- Embedding in the international POLARIS doctoral training network;
- Access to network-wide training activities, secondments and transferable-skills development;
- A challenging and translational research project at the interface of in vivo neuroscience, rare disease biology and preclinical therapy development;
- A collaborative and entrepreneurial working environment;
- An open and supportive team culture with opportunities for scientific and professional development.
Applications for the doctoral positions have now closed. The selection process is currently ongoing, and applications are being reviewed by the recruiting institutions.
POLARIS is now moving into the next phase of its doctoral programme, which will bring together a new cohort of researchers working across disciplines and sectors to advance translational research in leukodystrophies.













